Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Friday, May 16, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
admin
-
April 11, 2025
Latest Pharma-News
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
admin
-
April 9, 2025
Latest Pharma-News
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
admin
-
April 9, 2025
Latest Pharma-News
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
admin
-
April 9, 2025
Latest Pharma-News
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
admin
-
February 10, 2025
Latest Pharma-News
CHMP gives Sanofi positive opinion for Sarclisa for the treatment of relapsed and refractory multiple myeloma
admin
-
March 29, 2020
0
Latest Pharma-News
Detect COVID-19 in as little as 5 minutes-Abbott’s new diagnostic kit
admin
-
March 28, 2020
0
Latest Pharma-News
Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation
admin
-
March 28, 2020
0
Latest Pharma-News
Roche initiates Phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia
admin
-
March 25, 2020
0
Latest Pharma-News
Vivli to launch a portal for sharing data from COVID-19 trials
admin
-
March 25, 2020
0
Latest Pharma-News
Novartis will donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response
admin
-
March 25, 2020
0
Latest Pharma-News
CryoLife receives CE mark for E-vita Open Neo hybrid stent graft system for the treatment of aortic arch disease
admin
-
March 6, 2020
2
Latest Pharma-News
FDA grant Approval For Allergan’s durysta (Bimatoprost Implant) for Open-Angle Glaucoma Or Ocular Hypertension Patients
admin
-
March 6, 2020
0
Latest Pharma-News
U.S. Food and Drug Administration grants Orphan Drug Designation to TG Therapeutics for Umbralisib for the Treatment of Follicular Lymphoma
admin
-
March 6, 2020
0
Latest Pharma-News
USFDA Grants Rare Pediatric Disease Designation to Stealth BioTherapeutics for Elamipretide for the Treatment of Barth Syndrome
admin
-
March 4, 2020
0
Latest Pharma-News
FDA Informs Patients, Providers and Manufacturers About Potential Cybersecurity Vulnerabilities in the Certain Medical Devices with Bluetooth Low Energy
admin
-
March 4, 2020
0
Latest Pharma-News
KemPharm Submits KP415 NDA to USFDA for the Treatment of attention deficit hyperactivity disorder (ADHD)
admin
-
March 3, 2020
0
1
...
126
127
128
...
145
Page 127 of 145
- Advertisment -
Most Read
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
April 9, 2025
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
April 9, 2025